Robert L. Brainin - 05 Nov 2021 Form 4 Insider Report for CHAMPIONS ONCOLOGY, INC. (CSBR)

Role
Director
Signature
/s/ Robert L. Brainin
Issuer symbol
CSBR
Transactions as of
05 Nov 2021
Net transactions value
+$410,845
Form type
4
Filing time
30 Jan 2026, 12:15:54 UTC
Previous filing
16 Jan 2026
Next filing
30 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Brainin Robert Lawrence Director C/O CHAMPIONS ONCOLOGY, INC, ONE UNIVERSITY PLAZA, SUITE 307, HACKENSACK /s/ Robert L. Brainin 30 Jan 2026 0002088015

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CSBR Option to purchase Common Stock Award $100,000 +9,901 +123% $10.10 17,933 05 Nov 2021 Common Stock 9,901 $10.10 Direct F1
transaction CSBR Option to purchase Common Stock Award $98,910 +14,130 +79% $7.00 32,063 01 Nov 2022 Common Stock 14,130 $7.00 Direct F2
transaction CSBR Option to purchase Common Stock Award $105,076 +19,070 +59% $5.51 51,133 03 Nov 2023 Common Stock 19,070 $5.51 Direct F3
transaction CSBR Option to purchase Common Stock Award $106,859 +23,030 +45% $4.64 74,163 12 Nov 2024 Common Stock 23,030 $4.64 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and are exercisable over a twelve month period, with vesting to occur on November 5, 2021, February 5, 2022, May 5, 2022 and August 5, 2022, respectively.
F2 The options vest and are exercisable over a twelve month period, with vesting to occur on November 1, 2022, February 1, 2023, May 1, 2023 and August 1, 2023, respectively.
F3 The options vest and are exercisable over a twelve month period, with vesting to occur on November 3, 2023, February 3, 2024, May 3, 2024 and August 3, 2024, respectively.
F4 The options vest and are exercisable over a twelve month period, with vesting to occur on November 12, 2024, February 12, 2025, May 12, 2025 and August 12, 2025, respectively.